Literature DB >> 9869014

Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate.

C A Bomtempo1, G F Santos, R A Santos, M J Campagnole-Santos.   

Abstract

OBJECTIVE: Previous studies have shown that angiotensin-(1-7) potentiates the vascular actions of bradykinin. In the present study, we evaluated the interaction of bradykinin and angiotensin-(1-7) in the central modulation of baroreflex control of the heart rate.
MATERIALS AND METHODS: Blood pressure and reflex bradycardia, elicited by intravenous injection of phenylephrine, were evaluated in conscious male Wistar rats before and at the end of 1 h of an intracerebroventricular infusion of angiotensin-(1-7) at 0.5 or 1.0 microg/h combined with bradykinin at 2.5 microg/h; or angiotensin-(1-7) at 2.0 microg/h combined with bradykinin at 4.0 microg/h; or angiotensin-(1-7) alone at 2.0 or 4.0 microg/h; or bradykinin alone at 4.0 or 8.0 microg/h; or saline at 8 microl/h. In addition, baroreflex bradycardia was evaluated before and at the end of 1 and 2 h of intracerebroventricular infusion of angiotensin-(1-7) at 4 microg/h for 2 h; or saline at 8 microl/h in the first hour followed by HOE 140 at 90 ng/h in the second hour; or angiotensin-(1-7) at 4 microg/h in the first hour followed by angiotensin-(1-7) at 4 microg combined with HOE 140 at 90 ng/h in the second hour; or HOE 140 at 90 ng/h in the first hour followed by HOE 140 at 90th ng/h combined with angiotensin-(1-7) at 4 microg/h in the second hour; or saline at 8 microl/h for 2 h.
RESULTS: The intracerebroventricular infusion of angiotensin-(1-7) or bradykinin alone required a dose of 4.0 and 8.0 microg/h, respectively, to facilitate baroreflex control of the heart. However, a simultaneous infusion of these peptides at subeffective rates was able to produce a significant increase in baroreflex sensitivity. In addition, the facilitation of the baroreflex control of the heart rate induced by angiotensin-(1-7) at 4.0 microg/h was inhibited by HOE 140.
CONCLUSIONS: These results suggest that centrally, bradykinin and angiotensin-(1-7) can interact in order to modulate baroreflex control of the heart rate. In addition, our data indicate that the central modulatory effect of angiotensin-(1-7) on the baroreflex is mediated, at least in part, by the release of kinins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869014     DOI: 10.1097/00004872-199816120-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.

Authors:  Katsunori Isa; Amy C Arnold; Brian M Westwood; Mark C Chappell; Debra I Diz
Journal:  Hypertens Res       Date:  2011-09-22       Impact factor: 3.872

Review 2.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

3.  Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.

Authors:  Bruno D Cerrato; Oscar A Carretero; Brana Janic; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Angiotensin peptides and nitric oxide in cardiovascular disease.

Authors:  Kaushik P Patel; Harold D Schultz
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

6.  Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation.

Authors:  Fernanda S Zamo; Silvia Lacchini; Cristiano Mostarda; Silvana Chiavegatto; Ivana C M Silva; Edilamar Menezes Oliveira; Maria Claudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

7.  Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents.

Authors:  Małgorzata Sleszyńska; Tomasz H Wierzba; Krzysztof Malinowski; Tereza Tůmová; Bernard Lammek; Jiřina Slaninová; Adam Prahl
Journal:  Int J Pept Res Ther       Date:  2012-01-03       Impact factor: 1.931

8.  ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.

Authors:  Teng Jiang; Li Gao; Jie Lu; Ying-Dong Zhang
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 9.  Angiotensin-converting enzyme 2: central regulator for cardiovascular function.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

10.  Effects of bradykinin on venous capacitance in health and treated chronic heart failure.

Authors:  Prasad Gunaruwan; Abdul Maher; Lynne Williams; James Sharman; Matthias Schmitt; Ross Campbell; Michael Frenneaux
Journal:  Clin Sci (Lond)       Date:  2009-03       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.